chailab

Lab of @peterRchai focused on technologies to detect and change the human response to disease

[Peter Chai @PeterRchai]

New from our collaboration with Pathology @BrighamWomens @BrighamResearch - we assessed the performance of new generation #fentanyl assays to define their performance in clinical care:
https://t.co/xTQfjgFRaE

[chailab @chai_lab]

Lab mascot. #octopus

[Peter Chai @PeterRchai]

Coming back from another awesome #acmt2024 where we met our newest cohort of the ANTIDOTE program a r25 with @Dr_Carreiro and @NIDAnews. Awesome meeting Junior faculty toxicologists and hearing from POs at NIDA and NIAAA on k awards

[Peter Chai @PeterRchai]

Awesome work from our @BostonChildrens @BWHEmergencyMed @Harvard_Tox group on management of severe lead encelopathy #acmt2024

[Harvard CFAR @HarvardCFAR]

On 4/15 (12:30pm ET) @DrTiffanyGlynn presents her #HIV research in progress! @MGHPsychiatry @transSOCIALfl @TMPInc_org @ourtranshealth @FirstEventConf @BHCHP @BWHEmergencyMed @MGHPsychiatry @harvardmed #transwomen #HealthEquity #substanceusedisorders Info@ https://t.co/nIwYXsq7oO

[chailab @chai_lab]

Had a great session with @ARPA_H today @MIT discussing our experience and work with ingestible electronics in collaboration with @etectRx

[chailab @chai_lab]

Proud to join colleagues across the world to develop cannabis/cannabinoid guidelines for adults with cancer with @ASCO @DanaFarber @BrighamResearch: https://t.co/bUC8NhPWUW

[American College of Medical Toxicology @acmtmedtox]

Smartphone and Wearable Device-Based Digital Phenotyping to Understand Substance use and its Syndemics. READ IT HERE in @JMT_tweets >> https://t.co/U3n1ihIPlN

@PeterRchai @harvard_tox @brighamwomens @chai_lab @Dr_Carreiro @FenwayHealth @jslee_phd @k_deux_v

[chailab @chai_lab]

One of the most important things we wanted to do here was break down the #stigma barriers that individuals will substance use won't engage in technologies to address comorbid disease. This analysis shows that sub use was not associated with MSM willingness to use #digitalpills

[chailab @chai_lab]

From our lab with @DrTiffanyGlynn @jslee_phd and collaborators @khmayer1 @FenwayHealth @FordhamEthics work in @PLOSDigiHealth on how MSM on #PrEP think about #digitalpills and #digitalphenotyping

https://t.co/XsTH5TeHdn

[chailab @chai_lab]

Excited to share our new manuscript on formative usability and acceptability of digital pill systems for #heartfailure #adherence measurement using #digitalpills in @jmirpub

https://t.co/rSLjjsoLe2

[chailab @chai_lab]

Excited to participate with our close colleagues @MIT on the new @ARPA_H initiative to advance our knowledge and treatment of metabolic disease! @BWHEmergencyMed

https://t.co/MZ8fuIf35c

[chailab @chai_lab]

Discussing work by @DrTiffanyGlynn on understanding strategies to reach individuals with hiv risk using technologies in the emergency dept @HICSSnews #hicss57

[chailab @chai_lab]

Dr. Lee @jslee_phd presenting on work on #digitalpills and their application in #hiv #adherence monitoring in South Africa. In collaboration with @UCT_news #hicss57 @HICSSnews

[chailab @chai_lab]

Work with our colleagues @FenwayHealth on perspectives of sexual networking of MSM identifying as persons of color during COVID-19

https://t.co/OeScv5EOH4

[chailab @chai_lab]

New work from our group led by @Dr_GoldiTox on updates in current management of beta blocker and calcium channel blocker toxicity in European Heart Journal @ESC_Journals: https://t.co/PX3mdgTCy6

[NEJM @NEJM]

Although fentanyl is now the dominant driver of the U.S. opioid epidemic, our health care system has struggled to adapt toxicology screening practices to this reality. Read the Perspective by Drs. @BrianBarnettMD, @PeterRchai & Joji Suzuki: https://t.co/RquL3rIsYt

[Peter Chai @PeterRchai]

our perspective on increasing access to #fentanyl testing and increasing access to point of care testing for those with #oud @NEJM https://t.co/jyww46bDA4